News & Events
ALCOR Scientific is First Rhode Island Company to do Business in Iran, Post-Sanctions
ALCOR makes inroads into the Iranian healthcare market with the iSED – a highly accurate blood analyzer that allows laboratories to identify inflammation in patients in just 20 seconds
Smithfield, R.I. – August 4, 2016 – ALCOR Scientific today announced that it is the first Rhode Island-based company to do business in Iran in 15 years, following the lifting of international trade sanctions in January. With U.S.-Iran trade relations now open, ALCOR will be selling its iSED® Erythrocyte Sedimentation Rate Analyzer – a blood analyzer that identifies inflammation in patients – to Iranian hospitals and laboratories.
ALCOR Scientific Expands iSED® Analyzer to New Markets
Advanced Technology Delivers Results in Seconds Using Small Sample Smithfield, Rhode Island, July 24, 2014 – ALCOR Scientific, a provider of in vitro diagnostic analyzers and medical devices for enteral nutrition delivery, announced it has expanded availability of its iSED® system for erythrocyte sedimentation rate (ESR) testing to new markets to meet growing demand for this advanced technology. Initially launched in the US in late 2012, the iSED is CE marked and now available through distributors in Europe, Asia, Africa, South America and North America.
The iSED provides fully automated ESR testing – one of the most widely used lab tests worldwide, yet historically one of the most time-consuming and cumbersome to perform. The iSED transforms ESR testing by employing patented technology that delivers accurate results in 20 seconds using a blood sample of just 100uL, which is ideal when working with pediatric and geriatric patients. The iSED has a throughput of up to 180 samples per hour, made possible by its random access, continuous feed operation.